Reclassification of cardiovascular risk in patients with normal myocardial perfusion imaging using heart rate response to vasodilator stress

American Journal of Cardiology

Volumn 111, Issue 2, 2013, Pages 190-195

  Iqbal, Fahad M ^a   Al Jaroudi, Wael ^b   Sanam, Kumar ^c   Sweeney, Aaron ^a   Heo, Jaekyeong ^c   Iskandrian, Ami E ^c   Hage, Fadi G ^c,d  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Heart and Vascular Institute   (United States)

^c University of Alabama at Birmingham   (United States)

^d BIRMINGHAM VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; REGADENOSON;

ADULT; ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CAUSE OF DEATH; CONTINUOUS INFUSION; FEMALE; FOLLOW UP; FRAMINGHAM RISK SCORE; HEART DEATH; HEART INFARCTION; HEART RATE; HIGH RISK BEHAVIOR; HUMAN; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALE; MYOCARDIAL PERFUSION IMAGING; PHARMACOLOGIC STRESS TESTING; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SINGLE DRUG DOSE;

ADENOSINE; ALABAMA; CARDIOVASCULAR DISEASES; EXERCISE TEST; FEMALE; HEART RATE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL PERFUSION IMAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; VASODILATOR AGENTS;

EID: 84872024858     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2012.09.013     Document Type: Article

References (26)

1. P.W.F. Wilson, M. Pencina, P. Jacques, J. Selhub, R. D'Agostino, and C.J. O'Donnell C-reactive protein and reclassification of cardiovascular risk in the Framingham Heart Study Circ Cardiovasc Qual Outcomes 1 2008 92 97
2. S. Sivapalaratnam, S.M. Boekholdt, M.D. Trip, M.S. Sandhu, R. Luben, J.J.P. Kastelein, N.J. Wareham, and K.T. Khaw Family history of premature coronary heart disease and risk prediction in the EPIC-Norfolk prospective population study Heart 96 2010 1985 1989
3. H.M. Lee, H. Le, B.T. Lee, V.A. Lopez, and N.D. Wong Forced vital capacity paired with Framingham Kfor prediction of all-cause mortality Eur Respir J 36 2010 1002 1006
4. S.E. Elias-Smale, R.V. Proença, M.T. Koller, M. Kavousi, F.J.A. van Rooij, M.G. Hunink, E.W. Steyerberg, A. Hofman, M. Oudkerk, and J.C. Witteman Coronary calcium score improves classification of coronary heart disease risk in the elderly: the Rotterdam study J Am Coll Cardiol 56 2010 1407 1414
5. P.W. Wilson, R.B. D'Agostino, D. Levy, A.M. Belanger, H. Silbershatz, and W.B. Kannel Prediction of coronary heart disease using risk factor categories Circulation 97 1998 1837 1847
6. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report Circulation 106 2002 3143 3421
7. F.G. Hage, and A.E. Iskandrian Heart rate response during vasodilator stress myocardial perfusion imaging: mechanisms and implications J Nucl Cardiol 17 2010 536 539
8. A.E. Iskandrian, and E.V. Garcia Nuclear Cardiac Imaging: Principles and Applications 2008 Oxford University Press New York
9. A.E. Iskandrian, and E.V. Garcia Atlas of Nuclear Cardiology: Imaging Companion to Braunwald's Heart Disease 2011 Saunders Elsevier Philadelphia
10. S.M. Navare, J.F. Mather, L.J. Shaw, M.S. Fowler, and G.V. Heller Comparison of risk stratification with pharmacologic and exercise stress myocardial perfusion imaging: a meta-analysis J Nucl Cardiol 11 2004 5531 5561
11. L.J. Shaw, E.D. Peterson, L.K. Shaw, K.L. Kesler, E.R. DeLong, F.E. Harrell Jr., L.H. Muhlbaier, and D.B. Mark Use of a prognostic treadmill score in identifying diagnostic coronary disease subgroups Circulation 98 1998 1622 1630
12. F.G. Hage, P. Dean, F. Iqbal, J. Heo, and A.E. Iskandrian A blunted heart rate response to regadenoson is an independent prognostic indicator in patients undergoing myocardial perfusion imaging J Nucl Cardiol 18 2011 1086 1094
13. F.G. Hage, P. Dean, V. Bhatia, F. Iqbal, J. Heo, and A.E. Iskandrian The prognostic value of the heart rate response to adenosine in relation to diabetes mellitus and chronic kidney disease Am Heart J 162 2011 356 362
14. F.M. Iqbal, F.G. Hage, A. Ahmed, P.J. Dean, S. Raslan, J. Heo, and A.E. Iskandrian Comparison of the prognostic value of normal regadenoson to normal adenosine myocardial perfusion imaging using propensity score matching JACC Cardiovasc Imaging 5 2012 1014 1021
15. A.E. Iskandrian Stress-only myocardial perfusion imaging: a new paradigm J Am Coll Cardiol 55 2010 231 233
16. G. Germano, H. Kiat, P.B. Kavanagh, M. Moriel, M. Mazzanti, H.T. Su, K.F. Van Train, and D.S. Berman Automatic quantification of ejection fraction from gated myocardial perfusion SPECT J Nucl Med 36 1995 2138 2147
17. National Kidney Foundation K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification Am J Kidney Dis 39 2002 S1 S266
18. F.G. Hage, J. Heo, B. Franks, L. Belardinelli, B. Blackburn, W. Wang, and A.E. Iskandrian Differences in heart rate response to adenosine and regadenoson in patients with and without diabetes mellitus Am Heart J 157 2009 771 776
19. R. Hachamovitch, S.W. Hayes, J.D. Friedman, I. Cohen, and D.S. Berman Stress myocardial perfusion single-photon emission computed tomography is clinically effective and cost effective in risk stratification of patients with a high likelihood of coronary artery disease (CAD) but no known CAD J Am Coll Cardiol 43 2004 200 208
20. M.J. Pencina, R.B. D'Agostino, R.B. D'Agostino, and R.S. Vasan Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond Stat Med 27 2008 157 172
21. A. Rozanski, H. Gransar, S.W. Hayes, J.D. Friedman, R. Hachamovitch, and D.S. Berman Comparison of long-term mortality risk following normal exercise vs adenosine myocardial perfusion SPECT J Nucl Cardiol 17 2010 999 1008
22. L.J. Shaw, F.G. Hage, D.S. Berman, R. Hachamovitch, and A.E. Iskandrian Prognosis in the era of comparative effectiveness research: where is nuclear cardiology now and where should it be? J Nucl Cardiol 19 2012 1026 1043
23. R. Bhatheja, G.S. Francis, C.E. Pothier, and M.S. Lauer Heart rate response during dipyridamole stress as a predictor of mortality in patients with normal myocardial perfusion and normal electrocardiograms Am J Cardiol 95 2005 1159 1164
24. S. Mathur, A.R. Shah, A.W. Ahlberg, D.M. Katten, and G.V. Heller Blunted heart rate response as a predictor of cardiac death in patients undergoing vasodilator stress technetium-99m sestamibi gated SPECT myocardial perfusion imaging J Nucl Cardiol 17 2010 617 624
25. F.G. Hage, and A.E. Iskandrian Cardiac autonomic denervation in diabetes mellitus Circ Cardiovasc Imaging 4 2011 79 81
26. R.E. Maser, B.D. Mitchell, A.I. Vinik, and R. Freeman The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis Diabetes Care 26 2003 1895 1901